Stocks Hitting 52-Week Lows

Auris Medical Holding AG EARS shares touched a new 52-week low of $2.15 as the company issued results from TACTT2 trial with Keyzilen in acute inner ear tinnitus. The trial did not meet co-primary efficacy endpoints. The company also reported Q2 earnings of CHF0.25 per share.
Cerulean Pharma Inc CERU shares touched a new 52-week low of $1 on failed CRLX101/Avastin trial results. Leerink Swann, Janney Capital and JMP Securities downgraded the stock following the news.
DryShips Inc. DRYS shares dropped 8.1 percent to touch a new 52-week low of $0.960. DryShips shares have tumbled 96.93 percent over the past 52 weeks, while the S&P 500 index has gained 4.07 percent in the same period.
Bottomline Technologies EPAY shares reached a new 52-week low of $20.20. Bottomline Technologies shares have declined 23.14 percent over the past 52 weeks, while the S&P 500 index has gained 4.07 percent in the same period.